Positive Cash Flow and Adjusted EBITDA Improvement
In the first quarter, UGRO had positive cash flow from operations and delivered the strongest quarterly adjusted EBITDA results in two years, with a $3.1 million improvement year-over-year.
Revenue and Margin Growth
Revenue was reported at $15.5 million, with gross profit at $3.1 million or 20% of revenue. This is an improvement from 17% in the prior year period.
Reduction in Operating Expenses
Operating expenses decreased by $2.7 million year-over-year due to expense optimization efforts, and a $2.8 million improvement was realized in general and administrative expenses.
Strong Backlog
UGRO's backlog remained strong at $99 million, despite a slight sequential decrease.
Potential Industry Catalyst
The US Drug Enforcement Agency is reportedly supporting the reclassification of cannabis, which could lead to significant industry growth and increased working capital for operators.